Bill Requiring White House to Provide Sequestration Specifics Moves Forward
Client Alert | less than 1 min read | 07.27.12
Following bipartisan passage (414-2) in the House on July 18, the Senate on Wednesday passed the Sequestration Transparency Act of 2012 requiring OMB to prepare a report for Congress within 30 days identifying each account to be sequestered and the resulting reductions at the program, project, and activity level; itemizing all exempt accounts; and providing any other data and explanations necessary to enhance public understanding of the sequester. While the Administration initially opposed the Act, press reports now indicate that the President will likely sign the bill into law.
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
